Lizandra Marcondes
Senior VP, Medical Affairs Avertias Pharma
Seminars
Wednesday 28th January 2026
Overcoming Access & Adoption Barriers for Novel Non-Opioid Pain Therapies, a Medical Affairs Perspective
11:00 am
- Discuss strategies to shift prescribing away from opioids
- Share evidence generation strategies to pair new developments with real world evidence
- Evaluating health economic studies to prove how this strategy can fit into the market landscape in a way that is cost effective
Wednesday 28th January 2026
Fireside Chat: Balancing Real-World Realities & Scientific Rigor in Pain Trial Patient Selection
11:30 am
- Patients enter pain trials either after a drug washout period or while continuing their existing pain treatments, which influences baseline measurements.
- Answering how can trails be designed that accurately represent real-world patient populations while preserving scientific rigor